FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1997493612> ?p ?o ?g. }

• W1997493612 endingPage "689" @default.
• W1997493612 startingPage "689" @default.
• W1997493612 abstract "Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles Anamaria Orza,1,2 Olga Soriţău,3 Ciprian Tomuleasa,3,4 Liliana Olenic,5 Adrian Florea,4 Ovidiu Pana,5 Ioan Bratu,5 Emoke Pall,6 Stefan Florian,3 Dan Casciano,2 Alexandru S Biris21Faculty of Chemistry and Chemical Engineering, Babes-Bolyai University, Cluj-Napoca, Romania; 2Center for Integrative Nanotechnology Sciences, University of Arkansas at Little Rock, Little Rock, AR, USA; 3Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania; 4Faculty of General Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; 5National Institute for Research and Development of Isotopic and Molecular Technologies, Cluj-Napoca, Romania; 6Department of Research, University of Agriculture and Veterinary Medicine, Cluj-Napoca, RomaniaAbstract: The low rate of survival for patients diagnosed with glioblastoma may be attributed to the existence of a subpopulation of cancer stem cells. These stem cells have certain properties that enable them to resist chemotherapeutic agents and ionizing radiation. Herein, we show that temozolomide-loaded gold nanostructures are efficient in reducing chemoresistance and destroy 82.7% of cancer stem cells compared with a 42% destruction rate using temozolomide alone. Measurements of in vitro cytotoxicity and apoptosis indicate that combination with gold facilitated the ability of temozolomide, an alkylating drug, to alter the resistance of these cancer stem cells, suggesting a new chemotherapy strategy for patients diagnosed with inoperable recurrent malignant glioma.Keywords: gold nanoparticles, drug delivery, temozolomide therapy, temozolomide stability, cancer stem cells, recurrent high-grade gliomas" @default.
• W1997493612 created "2016-06-24" @default.
• W1997493612 creator A5006770891 @default.
• W1997493612 creator A5018413103 @default.
• W1997493612 creator A5026329148 @default.
• W1997493612 creator A5030543212 @default.
• W1997493612 creator A5045610788 @default.
• W1997493612 creator A5048593754 @default.
• W1997493612 creator A5064289237 @default.
• W1997493612 creator A5064829582 @default.
• W1997493612 creator A5086144565 @default.
• W1997493612 creator A5086520482 @default.
• W1997493612 creator A5086827328 @default.
• W1997493612 date "2013-03-01" @default.
• W1997493612 modified "2023-10-18" @default.
• W1997493612 title "Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles" @default.
• W1997493612 cites W1479799490 @default.
• W1997493612 cites W161090220 @default.
• W1997493612 cites W1972091231 @default.
• W1997493612 cites W1983466982 @default.
• W1997493612 cites W1984161308 @default.
• W1997493612 cites W1988049640 @default.
• W1997493612 cites W1988754095 @default.
• W1997493612 cites W1995392253 @default.
• W1997493612 cites W2013229653 @default.
• W1997493612 cites W2017341614 @default.
• W1997493612 cites W2017524562 @default.
• W1997493612 cites W2018107585 @default.
• W1997493612 cites W2019360402 @default.
• W1997493612 cites W2022122691 @default.
• W1997493612 cites W2035880310 @default.
• W1997493612 cites W2043585381 @default.
• W1997493612 cites W2049738552 @default.
• W1997493612 cites W2050321155 @default.
• W1997493612 cites W2051565538 @default.
• W1997493612 cites W2053419374 @default.
• W1997493612 cites W2059999322 @default.
• W1997493612 cites W2062006728 @default.
• W1997493612 cites W2063318887 @default.
• W1997493612 cites W2063986053 @default.
• W1997493612 cites W2067476451 @default.
• W1997493612 cites W2070042362 @default.
• W1997493612 cites W2084888059 @default.
• W1997493612 cites W2096287682 @default.
• W1997493612 cites W2099562625 @default.
• W1997493612 cites W2100245749 @default.
• W1997493612 cites W2112944130 @default.
• W1997493612 cites W2118758371 @default.
• W1997493612 cites W2126193697 @default.
• W1997493612 cites W2130926378 @default.
• W1997493612 cites W2132317474 @default.
• W1997493612 cites W2143425711 @default.
• W1997493612 cites W2147893852 @default.
• W1997493612 cites W2159594070 @default.
• W1997493612 cites W2159640574 @default.
• W1997493612 cites W2184054871 @default.
• W1997493612 cites W2283949504 @default.
• W1997493612 cites W2322108690 @default.
• W1997493612 cites W2399475545 @default.
• W1997493612 cites W2413984899 @default.
• W1997493612 cites W2519345588 @default.
• W1997493612 cites W3023255929 @default.
• W1997493612 cites W618788809 @default.
• W1997493612 doi "https://doi.org/10.2147/ijn.s37481" @default.
• W1997493612 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3589121" @default.
• W1997493612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23467447" @default.
• W1997493612 hasPublicationYear "2013" @default.
• W1997493612 type Work @default.
• W1997493612 sameAs 1997493612 @default.
• W1997493612 citedByCount "45" @default.
• W1997493612 countsByYear W19974936122013 @default.
• W1997493612 countsByYear W19974936122014 @default.
• W1997493612 countsByYear W19974936122015 @default.
• W1997493612 countsByYear W19974936122016 @default.
• W1997493612 countsByYear W19974936122017 @default.
• W1997493612 countsByYear W19974936122018 @default.
• W1997493612 countsByYear W19974936122019 @default.
• W1997493612 countsByYear W19974936122020 @default.
• W1997493612 countsByYear W19974936122021 @default.
• W1997493612 countsByYear W19974936122022 @default.
• W1997493612 countsByYear W19974936122023 @default.
• W1997493612 crossrefType "journal-article" @default.
• W1997493612 hasAuthorship W1997493612A5006770891 @default.
• W1997493612 hasAuthorship W1997493612A5018413103 @default.
• W1997493612 hasAuthorship W1997493612A5026329148 @default.
• W1997493612 hasAuthorship W1997493612A5030543212 @default.
• W1997493612 hasAuthorship W1997493612A5045610788 @default.
• W1997493612 hasAuthorship W1997493612A5048593754 @default.
• W1997493612 hasAuthorship W1997493612A5064289237 @default.
• W1997493612 hasAuthorship W1997493612A5064829582 @default.
• W1997493612 hasAuthorship W1997493612A5086144565 @default.
• W1997493612 hasAuthorship W1997493612A5086520482 @default.
• W1997493612 hasAuthorship W1997493612A5086827328 @default.
• W1997493612 hasBestOaLocation W19974936121 @default.
• W1997493612 hasConcept C121608353 @default.
• W1997493612 hasConcept C126322002 @default.
• W1997493612 hasConcept C143998085 @default.
• W1997493612 hasConcept C171250308 @default.

• next